ABBV vs GSBD · P/E 81, rev $16.99B vs P/E 14, $997.4M cap
AbbVie Inc (ABBV) versus Goldman Sachs BDC Inc (GSBD) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Goldman Sachs BDC Inc (GSBD) is a asset management company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
GSBD does not have a complete income-statement cache yet.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. GSBD currently screens at market cap $997.4M and trailing P/E 13.8.
Not investment advice. Open the ABBV and GSBD stock pages for the full models.
Not investment advice.